A. van Tol
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Biochemistry top 2%
- Lipid metabolism and biosynthesis
Papers in
-
- Mitochondrial Function and Pathology 6
- Metabolism, Diabetes, and Cancer 4
- Metabolomics and Mass Spectrometry Studies 4
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Co-authors
- W.C. Hülsmann (5 shared papers)Hans Jansen (2 shared papers)William J. Black (3 shared papers)Geesje M. Dallinga‐Thie (5 shared papers)B.L. Horecker (2 shared papers)Jan Willem de Jong (2 shared papers)Teus van Gent (2 shared papers)F. Vlaspolder (1 shared paper)
- Journals
- Biochimica et Biophysica Acta (BBA) - Bioenergetics (4 papers)Archives of Biochemistry and Biophysics (3 papers)Atherosclerosis (3 papers)Biochemical and Biophysical Research Communications (2 papers)Atherosclerosis Supplements (2 papers)
- Partner nations
- NetherlandsUnited StatesJapan
In The Last Decade
A. van Tol
28 papers receiving 873 citations
Peers
Comparison fields: 5 of 72
- Clinical Biochemistry 155
- Biochemistry 169
- Endocrinology, Diabetes and Metabolism 330
- Cancer Research 193
- Physiology 155
Countries citing papers authored by A. van Tol
This map shows the geographic impact of A. van Tol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. van Tol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. van Tol more than expected).
Fields of papers citing papers by A. van Tol
This network shows the impact of papers produced by A. van Tol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. van Tol. The network helps show where A. van Tol may publish in the future.
Co-authors
The 25 scholars most cited alongside A. van Tol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 228 | |
| 2 | 1972 | 81 | |
| 3 | 2006 | 64 | |
| 4 | 1978 | 62 | |
| 5 | 2007 | 57 | |
| 6 | 1969 | 55 | |
| 7 | 2007 | 51 | |
| 8 | 1970 | 49 | |
| 9 | 1972 | 43 | |
| 10 | 2001 | 34 | |
| 11 | 1975 | 34 | |
| 12 | 1968 | 33 | |
| 13 | 1986 | 29 | |
| 14 | 1969 | 22 | |
| 15 | 1974 | 19 | |
| 16 | 1970 | 18 | |
| 17 | 1970 | 16 | |
| 18 | 1998 | 12 | |
| 19 | 1985 | 12 | |
| 20 | 1975 | 6 |
About A. van Tol
A. van Tol is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research, Surgery and Epidemiology, having authored 28 papers that have together received 939 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Mitochondrial Function and Pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Metabolism and Genetic Disorders (4 papers), Cancer, Lipids, and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Clinical Biochemistry (155 citations), Biochemistry (169 citations), Endocrinology, Diabetes and Metabolism (330 citations), Cancer Research (193 citations) and Physiology (155 citations). A. van Tol has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include W.C. Hülsmann, Hans Jansen, William J. Black, Geesje M. Dallinga‐Thie, B.L. Horecker, Jan Willem de Jong, Teus van Gent, F. Vlaspolder, B.L. Horecker and Bruce H. R. Wolffenbuttel. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Bioenergetics, Archives of Biochemistry and Biophysics, Atherosclerosis, Biochemical and Biophysical Research Communications and Atherosclerosis Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.